Skip to main content

Table 2 Incidence of emergence agitation among studied groups

From: Comparison between dexmedetomidine versus magnesium sulfate infusions for mitigating emergence agitation in obese adults undergoing nasal surgery

RASS level

C group (n = 35)

D group

(n = 35)

M group (n = 35)

P values

Level

Terms

n (%)

n (%)

n (%)

 

+ 4

Combative

1 (2.85)

0 (0)

0 (0)

0.132

+ 3

Very agitated

2 (5.6)

0 (0) †

0 (0) †

0.041

+ 2

Agitated

7 (20)

1(2.85) †

1(2.85) †

0.031*

+ 1

Restless

9 (25)

1 (2.85) †

2 (5.6) †

0.012*

Total

19 (54.2)

2 (5.6) †

3 (8.5) †

0.001*

  1. Abbreviations: n Number of patients, RASS Richmond agitation sedation score, C Control, D Dexmedetomidine, M Magnesium sulfate
  2. Notes: Our primary end point was occurrence of emergence agitation. It was defined as Richmond Agitation Sedation Scale (RASS) of ≥+ 1 during the time interval between turning off anesthetics till the patient was eligible to leave the PACU (Aldrete score of ≥ 9). Agitation is defined as ≥+ 1 RASS level. *P value is < 0.05, among the groups using one-way ANOVA test; †p < 0.017 is significant compared to C group using Wilcoxon Mann-Whitney U test; values are presented as number of patients (%) or absolute number (N)